GLAUKOS CORP (GKOS) Stock News
NYSE:GKOS - New York Stock Exchange, Inc. - US3773221029 - Common Stock - Currency: USD
GKOS Latest News, Press Relases and Analysis
This Parsons Analyst Is No Longer Bullish; Here Are Top 3 Downgrades For Thursday
Glaukos (GKOS) Q1 Earnings: Taking a Look at Key Metrics Versus Estimates
The headline numbers for Glaukos (GKOS) give insight into how the company performed in the quarter ended March 2025, but it may be worthwhile to compare some of its key metrics to Wall Street estimates and the year-ago actuals.
GKOS Stock Falls Despite Q1 Earnings & Revenue Beat, Margins Decline
Glaukos' first-quarter results showcase a strong uptick in revenues. However, continued operating loss remains a cause of concern.
UPS downgraded, ServiceNow upgraded: Wall Street's top analyst calls
UPS downgraded, ServiceNow upgraded: Wall Street's top analyst calls
Glaukos (GKOS) Reports Q1 Loss, Tops Revenue Estimates
Glaukos (GKOS) delivered earnings and revenue surprises of 33.33% and 3.84%, respectively, for the quarter ended March 2025. Do the numbers hold clues to what lies ahead for the stock?
Mentions: MTD
Here's Why You Should Add Veeva Stock to Your Portfolio Now
VEEV's robust product portfolio and a slew of strategic deals raise optimism about the stock.
Glaukos Announces First Quarter 2025 Financial Results
ECL Stock Up in Pre-Market Following Q1 Earnings Meet Estimates
Ecolab's robust performance across the majority of its segments drives its first-quarter organic sales despite business challenges.
RVTY Rises as Q1 Earnings & Sales Beat Estimates, '25 Sales View Up
Revvity's first-quarter results showcase strong growth in Diagnostics business, along with recovery in Life Sciences segmental sales.
Avantor Stock Declines Despite Q1 Earnings In-Line, Revenues Down Y/Y
AVTR's Bioscience Production segment witnesses robust growth amid macroeconomic pressures.
WST Stock Rises on Q1 Earnings Beat, EPS View Up on Tariff & FX Benefit
West Pharmaceutical's first-quarter top line continues to benefit from revenue growth in its Proprietary Products segment.
Earnings Preview: Mettler-Toledo (MTD) Q1 Earnings Expected to Decline
Mettler-Toledo (MTD) doesn't possess the right combination of the two key ingredients for a likely earnings beat in its upcoming report. Get prepared with the key expectations.
Mentions: MTD
ISRG Stock Falls Despite Q1 Earnings Beat, Gross Margin Contracts
ISRG's first-quarter results reflect a healthy demand for procedures on higher system utilization. However, tariffs lead to a decline in the gross margin outlook.
Glaukos (GKOS) May Report Negative Earnings: Know the Trend Ahead of Next Week's Release
Glaukos (GKOS) doesn't possess the right combination of the two key ingredients for a likely earnings beat in its upcoming report. Get prepared with the key expectations.
Glaukos Announces the Release of its 2024 Sustainability Report
Glaukos to Release First Quarter 2025 Financial Results after Market Close on April 30
What Makes Glaukos Corporation (GKOS) a Compelling Stock?
ClearBridge Investments, an investment management company, released its “ClearBridge Small Cap Growth Strategy” first quarter 2025 investor letter. A copy of the letter can be downloaded here. The stock market performance in the first quarter of 2025 was volatile, following the initial “animal spirits” post-election rally. The strategy surpassed its benchmark with the support of […]
Clean Harbors, Inc. (CLH): Among Stocks with Buy Ratings that Hedge Funds Love
We recently published a list of 15 Stocks with Buy Ratings that Hedge Funds Love. In this article, we are going to take a look at where Clean Harbors, Inc. (NYSE:CLH) stands against other stocks with buy ratings that hedge funds love. The U.S. stock market has been in chaos ever since President Trump announced […]
3 Stocks to Watch in the Evolving Cell-Based Ophthalmic Therapy Space
ALC, GKOS and REGN are well-positioned to benefit from the evolving space of cell-based ophthalmic therapy.
Glaukos Announces FDA Acceptance of NDA Submission for Epioxa™
Glaukos Announces Fourth Quarter and Full Year 2024 Financial Results
Electronic Arts initiated, Workday downgraded: Wall Street's top analyst calls
Electronic Arts initiated, Workday downgraded: Wall Street's top analyst calls